A

Adaptimmune Therapeutics plc
D

ADAP

0.59970
USD
0.01
(0.84%)
مغلق
حجم التداول
31,015
الربح لكل سهم
-0
العائد الربحي
-
P/E
-4
حجم السوق
153,453,159
أصول ذات صلة
الأخبار

العنوان: Adaptimmune Therapeutics plc

القطاع: Healthcare
الصناعة: Biotechnology
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.